Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?

od Kauffmann, Rondi M., Hamner, J. Blair, Ituarte, Philip H. G., Yim, John H.
izdano v BMC Cancer (2018)

IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition

od Armstrong, Michaele J, Stang, Michael T, Liu, Ye, Yan, Jin, Pizzoferrato, Eva, Yim, John H
izdano v Cancer Biol Ther (2015)

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer

od Han, Ernest S., Wen, Wei, Dellinger, Thanh H., Wu, Jun, Lu, Selena A., Jove, Richard, Yim, John H.
izdano v Oncotarget (2018)

Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer

od Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Lu, Leander X., Wu, Jun, Jove, Richard, Yim, John H.
izdano v Cancers (Basel) (2020)

Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer

od Yuan, Yuan, Wen, Wei, Yost, Susan E., Xing, Quanhua, Yan, Jin, Han, Ernest S., Mortimer, Joanne, Yim, John H.
izdano v Sci Rep (2019)

IRF-1 regulates alternative mRNA splicing of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in breast epithelial cells generating an immunoreceptor tyrosine-ba...

od Dery, Kenneth J, Kujawski, Maciej, Grunert, David, Wu, Xiwei, Ngyuen, Tung, Cheung, Celeste, Yim, John H, Shively, John E
Izdano 2014

Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer

od Phan, Thuy, Nguyen, Vu H., A’lincourt Salazar, Marcela, Wong, Paul, Diamond, Don J., Yim, John H., Melstrom, Laleh G.
izdano v Mol Ther Oncolytics (2020)

Letters to the Editor

od Yim, John H., Barton, Premsri, Weber, Beverly, Radford, Diane, Levy, Jerome, Monsees, Barbara, Flanagan, Fidelma, Norton, Jeffrey A., Doherty, Gerard M.
Izdano 1997

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer

od Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Wu, Jun, Guo, Yuming, Buettner, Ralf, Horne, David A., Jove, Richard, Yim, John H.
izdano v Transl Oncol (2019)

Interferon Regulatory Factor 1 (IRF-1) Induces p21(WAF1/CIP1) Dependent Cell Cycle Arrest and p21(WAF1/CIP1) Independent Modulation of Survivin in Cancer Cells

od Armstrong, Michaele J., Stang, Michael T., Liu, Ye, Gao, Jinbo, Ren, Baoguo, Zuckerbraun, Brian S., Mahidhara, Raja S., Xing, Quanhua, Pizzoferrato, Eva, Yim, John H.
Izdano 2011

Evaluation of Expert Criteria for Preoperative Magnetic Resonance Imaging of Newly Diagnosed Breast Cancer

od Behrendt, Carolyn E., Tumyan, Lusine, Gonser, Laura, Shaw, Sara L., Vora, Lalit, Paz, I. Benjamin, Ellenhorn, Joshua D.I., Yim, John H.
Izdano 2014

Ad-IRF-1 Induces Apoptosis in Esophageal Adenocarcinoma

od Watson, Gregory A, Queiroz de Oliveira, Pierre E, Stang, Michael T, Armstrong, Michaele J, Gooding, William E, Kuan, Shih-Fan, Yim, John H, Hughes, Steven J
Izdano 2006

Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

od Wen, Wei, Wu, Jun, Liu, Lucy, Tian, Yan, Buettner, Ralf, Hsieh, Meng-Yin, Horne, David, Dellinger, Thanh H, Han, Ernest S, Jove, Richard, Yim, John H
izdano v Mol Cancer (2015)

Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes

od Wang, Lei, Simons, Diana L., Lu, Xuyang, Tu, Travis Y., Avalos, Christian, Chang, Andrew Y., Dirbas, Frederick M., Yim, John H., Waisman, James, Lee, Peter P.
izdano v EBioMedicine (2020)

Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplati...

od Shinde, Arvind M., Zhai, Jing, Yu, Kim Wai, Frankel, Paul, Yim, John H., Luu, Thehang, Kruper, Laura, Vito, Courtney, Shaw, Sally, Vora, Nayana L., Kirschenbaum, Michele, Somlo, George
izdano v Breast (2014)

Human breast tumor-infiltrating CD8(+) T cells retain polyfunctionality despite PD-1 expression

od Egelston, Colt A., Avalos, Christian, Tu, Travis Y., Simons, Diana L., Jimenez, Grecia, Jung, Jae Y., Melstrom, Laleh, Margolin, Kim, Yim, John H., Kruper, Laura, Mortimer, Joanne, Lee, Peter P.
izdano v Nat Commun (2018)

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer

od Wen, Wei, Marcinkowski, Emily, Luyimbazi, David, Luu, Thehang, Xing, Quanhua, Yan, Jin, Wang, Yujun, Wu, Jun, Guo, Yuming, Tully, Dylan, Han, Ernest S., Yost, Susan E., Yuan, Yuan, Yim, John H.
izdano v Cells (2019)

Sentinel lymph node B cells can predict disease-free survival in breast cancer patients

od Blenman, Kim R. M., He, Ting-Fang, Frankel, Paul H., Ruel, Nora H., Schwartz, Erich J., Krag, David N., Tan, Lee K., Yim, John H., Mortimer, Joanne E., Yuan, Yuan, Lee, Peter P.
izdano v NPJ Breast Cancer (2018)

Identification of a Natural Compound by Cell-Based Screening that Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression

od Gao, Jinbo, Wang, Yujun, Xing, Quanhua, Yan, Jin, Senthil, Maheswari, Akmal, Yasir, Kowolik, Claudia M., Kang, Julia, Lu, David M., Zhao, Ming, Lin, Zhixiu, Cheng, Christopher H.K., Yip, M.L. Richard, Yim, John H.
Izdano 2011

Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12

od Chung, Brile, Esmaeili, Ali A., Gopalakrishna-Pillai, Sailesh, Murad, John P., Andersen, Emily S., Kumar Reddy, Naveen, Srinivasan, Gayathri, Armstrong, Brian, Chu, Caleb, Kim, Young, Tong, Tommy, Waisman, James, Yim, John H., Badie, Behnam, Lee, Peter P.
izdano v NPJ Breast Cancer (2017)